Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
NCT06721260 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-03-20
Summary
This study is being done to learn more about energy needs and muscle function during treatment for bladder cancer. These insights can help improve future patient care. The study team found in a previous study that resting energy can be different than what estimates show. Patients with bladder cancer are known to suffer a decline in physical resilience over time. Monitoring patients to understand these changes better could help design future treatments with these vulnerabilities in mind.
Conditions
Sponsors & Collaborators
-
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Jill M Hamilton-Reeves, PhD, RD, CSO · University of Kansas Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-21
- Primary Completion
- 2027-01-31
- Completion
- 2027-06-30
Countries
- United States
Study Locations
More Related Trials
-
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
NCT05672615 ·Status: RECRUITING
-
Bladder Cancer Patient-Reported Outcomes
NCT01090388 ·Status: COMPLETED
-
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05982561 ·Status: RECRUITING
-
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
NCT04144270 ·Status: UNKNOWN
-
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.
NCT06289270 ·Status: RECRUITING
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection
NCT05767528 ·Status: UNKNOWN
-
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
NCT07225127 ·Status: RECRUITING
-
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
NCT06289283 ·Status: ACTIVE_NOT_RECRUITING
-
Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
NCT02861196 ·Status: COMPLETED ·Phase: NA
-
Urine VOC Investigation in Bladder Cancer Diagnosis
NCT05671289 ·Status: COMPLETED
-
A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer
NCT06735287 ·Status: RECRUITING ·Phase: NA
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
NCT06986304 ·Status: RECRUITING
-
Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy
NCT07053722 ·Status: NOT_YET_RECRUITING
-
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
NCT02852564 ·Status: COMPLETED ·Phase: PHASE1
-
Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma
NCT00867620 ·Status: UNKNOWN
-
SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly
NCT03362801 ·Status: RECRUITING ·Phase: NA
-
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits
NCT06193941 ·Status: COMPLETED
-
Drug Screening Using IMD in Bladder Cancer
NCT06204614 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
NCT07261592 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT02657486 ·Status: COMPLETED ·Phase: NA
-
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
NCT02735512 ·Status: TERMINATED
-
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
NCT06488222 ·Status: RECRUITING ·Phase: PHASE2
-
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
NCT02992990 ·Status: UNKNOWN ·Phase: NA